Retinoic acid embryopathy: report of two cases associated with the use of isotretinoin
DOI:
https://doi.org/10.11606/issn.2317-0190.v15i1a102914Keywords:
Fetal Diseases, Goldenhar Syndrome, Tretinoin, IsotretinoínaAbstract
The authors report two cases associated with the use of isotretinoin before or during the gestational period, with its characteristic aspects and variations, of one male and one female child. This report aims at raising the awareness of medical professionals about the possible risk of isotretinoin administration to fertile-aged women considering the severity of malformations in the different systems of the human body.
Downloads
References
Jones K. Embriopatia do ácido retinóico. In: Padrões reconhecíveis de malformações congênitas. São Paulo: Manole; 1998. p. 572-3.
Jones K. Espectro óculo-aurículo-vertebral. Padrões reconhecíveis de malformações congênitas. São Paulo: Manole; 1998. p. 642-5.
Verona LL, Damian NG, Pavarina LP, Ferreira CH, Melo DG. Monozygotic twins discordant for Goldenhar syndrome. J Pediatr. 2006;82(1):75-8.
Mocellin M, Capasso R, Catani GSA, Gasperin, AC, Wzzoto AOJ. Síndrome de Goldenhar (displasia oculoauriculovertebral): relato de caso e revisao de literatura. Rev Bras Otorrinolaring.1998;64(1):77-9.
Nau H. Teratogenicity of isotretinoin revisited: species variation and the role of alltrans- retinoic acid. J Am Acad Dermatol. 2001;45(5):S183-7.
Ellis CN, Krach KJ. Uses and complications of isotretinoin therapy. J Am Acad Dermatol. 2001;45(5):S150-7.
Azulay DR. Atualização em retinóides [texto na Internet]. Rio de Janeiro: [citado citado 2008 jan 15]. Disponível em: www.dermato-santacasa.com.br/producao/azulay_retinoides.pdf
Isotretinoína [bula de remédio]. Responsável técnico Guilherme N. Ferreira. Rio de Janeiro: Roche Químicos e Farmacêuticos; 2004 [citado 2008 jan 19]. Disponível em: http://bulario.bvs.br/index.php?action=search.2004031817130733009945000123&mode=dir&letter=M
Downloads
Published
Issue
Section
License
Copyright (c) 2008 Acta Fisiátrica
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
